Raloxifene Evista

  • Facts:
    Oral, selective estrogen receptor modulator (SERM)
    Mixed agonist/antagonist of estrogen receptors
    Estrogenic actions on bones and anti-estrogenic effects on uterus and breast
  • Indications:
    First line agent for the prevention of osteoporosis , while decreasing risk for breast cancer
  • Side Effects:
    Increased risk for thromboembolic events

Review Edit Entry New Entry

August 7th 2010